Posted By John Morris On 26 Jan 2026 Comments (9)
The FDA has overhauled generic drug approval rules between 2023 and 2025 to boost U.S. manufacturing. Learn how the new pilot program speeds up approvals, affects drug prices, and impacts patients and manufacturers.
READ MORE